Dataset Information

COVID-19 health certification reduces outgroup bias: evidence from a conjoint experiment in Japan.

ABSTRACT: The psychological theory argues that serious threats cause negative attitudes from ingroups to outgroups. However, the factors that can reduce such outgroup bias caused by the health threats of a pandemic are unknown. Here, we provide evidence that health certifications to prove immunity or negative test result for COVID-19 reduce outgroup bias. Using a discrete choice experiment with a randomized conjoint design in Japan, we investigated public attitudes towards inbound travelers entering the country, including foreigners, immigrants, and tourists. We found that travelers carrying a vaccination certificate or a negative test result for COVID-19 have a higher probability or rating of being admitted to the country. These effects are the same size as those for travelers undergoing self-isolation. Thus, our results demonstrate that health certification can mitigate outgroup bias among ingroup members experiencing threats to health due to the COVID-19 pandemic. We anticipate that the findings would support the combined usage of vaccine passports and negative certificates to reopen the international borders.

SUBMITTER: Kubo Y

PROVIDER: S-EPMC9462644 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

COVID-19 health certification reduces outgroup bias: evidence from a conjoint experiment in Japan.

Kubo Yoshiaki Y Okada Isamu I

Humanities & social sciences communications 20220909 1

The psychological theory argues that serious threats cause negative attitudes from ingroups to outgroups. However, the factors that can reduce such outgroup bias caused by the health threats of a pandemic are unknown. Here, we provide evidence that health certifications to prove immunity or negative test result for COVID-19 reduce outgroup bias. Using a discrete choice experiment with a randomized conjoint design in Japan, we investigated public attitudes towards inbound travelers entering the c ...[more]

PMID: 36105276

Similar Datasets

Project description:IntroductionDuring the recent coronavirus disease 2019 (COVID-19) pandemic, preferences for factors associated with vaccines have been evaluated. Three oral antiviral drugs have been approved in Japan for patients with mild-to-moderate I COVID-19 symptoms. Although preferences for the drugs may also depend on various factors, these have not been fully evaluated.MethodsA conjoint analysis was performed based on an online survey in August 2022 to estimate the intangible costs of factors associated with oral antiviral drugs for COVID-19. Respondents were individuals aged 20-69 across Japan. The attributes included the company (Japanese/foreign) that developed the drug, formulation and size of the drug, frequency of administration per day, number of tablets/capsules per dose, number of days until no longer infectious to others, and out-of-pocket expenses. A logistic regression model was applied to estimate the utility of each level for each attribute. The intangible costs were calculated by comparing the utility to the out-of-pocket attribute.ResultsResponses were collected from 11,303 participants. The difference between levels was the largest for companies that developed a drug; the intangible costs were JPY 5390 higher for the foreign company than for the Japanese company. The next largest difference was in the number of days until one is no longer infectious. For the same formulation, the intangible cost was lower for small sizes than large sizes. For similar-sized tablets and capsules, the intangible cost was lower for tablets than capsules. These tendencies were similar regardless of COVID-19 infection history and the presence of risk factors for severe COVID-19 in the respondents.ConclusionIntangible costs for factors associated with oral antiviral drugs among the Japanese population were estimated. The results may change as the number of people with a history of COVID-19 infection increases and significant progress is made regarding treatments.

Dataset Information

COVID-19 health certification reduces outgroup bias: evidence from a conjoint experiment in Japan.

Publications

COVID-19 health certification reduces outgroup bias: evidence from a conjoint experiment in Japan.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets